Clinical Value of Autoantibodies Against C1q in Children With Glomerulonephritis
- 1 May 2006
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 117 (5) , 1663-1668
- https://doi.org/10.1542/peds.2005-1148
Abstract
OBJECTIVE. Autoantibodies against C1q (anti-C1q) have been found in a number of autoimmune and renal diseases. They are best described in adult patients with systemic lupus erythematosus, where a strong correlation between the occurrence of anti-C1q and severe lupus nephritis (LN) has been observed. However, the role of anti-C1q in children with systemic lupus erythematosus has not yet been determined. Furthermore, the clinical importance of anti-C1q in other forms of glomerulonephritis remains to be elucidated. The aim of this study was to investigate anti-C1q in children with different forms of glomerulonephritis including LN.METHODS. We prospectively investigated 112 children with different forms of newly diagnosed glomerulonephritis for the presence of anti-C1q by an enzyme-linked immunosorbent assay and compared them with healthy controls. Associations between anti-C1q and disease manifestations at the time of the measurements and during follow-up were investigated.RESULTS. Twenty-one of 112 patients were positive for anti-C1q compared with 0 of 40 healthy controls. Anti-C1q was associated with activity in LN and with disease severity in patients with acute poststreptococcal glomerulonephritis (APSGN). In LN, 7 of 12 patients were found to be anti-C1q positive. Six of these 7 had active disease at the time of the serum sampling compared with 1 of 5 of the anti-C1q-negative children. In children with APSGN, 8 of 24 were positive for anti-C1q. Anti-C1q-positive APSGN patients had significantly higher proteinuria and more often hypertension than those without anti-C1q. All 4 patients in which APSGN did not resolve spontaneously were anti-C1q positive.CONCLUSIONS. Anti-C1q is associated with active LN in children. In addition, children with anti-C1q-positive APSGN have more severe disease than those who are anti-C1q negative. These data suggest APSGN is another disease in which anti-C1q has a pathogenic role.Keywords
This publication has 23 references indexed in Scilit:
- Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonistClinical and Experimental Nephrology, 2003
- Pathogenic Mechanism of Acute Post-Streptococcal GlomerulonephritisScandinavian Journal of Infectious Diseases, 1999
- Antibodies to C1q in systemic lupus erythematosus: Characteristics and relation to FcγRIIA allelesKidney International, 1997
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosusAmerican Journal of Kidney Diseases, 1995
- Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical and Serologic Findings in 18 PatientsMedicine, 1995
- Short-Term Kinetics of the Humoral Anti-Clq Response in SLE Using the ELISPOT Method: Fast Decline in Production in Response to SteroidsScandinavian Journal of Immunology, 1994
- Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1993
- Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.Journal of Clinical Investigation, 1988
- Complement Components and Complement Activation in Acute Poststreptococcal GlomerulonephritisInternational Archives of Allergy and Immunology, 1979